Colistimethate Sodium
SIAL/PHR1737 - Pharmaceutical Secondary Standard; Certified Reference Material
Synonym: Colistimethate sodium; CMS; Colistin sulphomethate sodium
CAS Number: 8068-28-8
EC Number: 232-516-9
Product Type: Chemical
agency | traceable to Ph. Eur. C2600000 |
traceable to USP 1147009 | |
API family | colistimethate |
application(s) | pharmaceutical (small molecule) |
CofA | current certificate can be downloaded |
format | neat |
grade | certified reference material |
pharmaceutical secondary standard | |
InChI | 1S/C58H110N16O28S5.5Na/c1 |
InChI key | IQWHCHZFYPIVRV-UHFFFAOYSA |
packaging | pkg of 500 mg |
Quality Level | 300 |
storage temp. | -10 to -25°C |
technique(s) | gas chromatography (GC): suitable |
HPLC: suitable |
Analysis Note: | These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. |
Application: | Colistimethate Sodium may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by high performance liquid chromatography (HPLC). |
Application: | These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. |
Footnote: | To see an example of a Certificate of Analysis for this material enter LRAA8043 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. |
General description: | Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Colistimethate Sodium belongs to the class of polymyxin antibiotics that acts by inhibiting the Gram negative bacteria. It is a prodrug that can hydrolyze to colistin in vivo or in vitro. It is employed as a last resort antibiotic to treat Pseudomonas aeruginosa infection in cystic fibrosis patients. |
Other Notes: | This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | -10 to -25°C |
UNSPSC | 41116107 |